BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
BriaCell and its majority-owned subsidiary BriaPro will present four posters at the SITC 41st Annual Meeting, held November 4-8, 2026, in Phoenix, AZ. The accepted abstracts cover preclinical research on BriaCell's Bria-OTS+ personalized off-the-shelf immunotherapy and BriaPro's tumor-targeted checkpoint inhibitors, including soluble CD80 (BP-80) and engineered CD80 variants.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.